Celcuity (CELC) Receivables - Accured (2025)
Celcuity (CELC) posted Receivables - Accured of $436.5 million for Q4 2025.
Celcuity (CELC) Receivables - Accured (2025) Analysis & Trends
Celcuity's Receivables - Accured history runs 1 years deep, the most recent figure standing at $436.5 million for Q4 2025.
- Quarterly Receivables - Accured changed N/A year-over-year to $436.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $436.5 million (changed N/A YoY) and the FY2025 annual result came in at $436.5 million, changed N/A from the prior year.
- Receivables - Accured was $436.5 million for Q4 2025 at Celcuity.
- Across five years, Receivables - Accured topped out at $436.5 million in Q4 2025 and bottomed at $436.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - | 436.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 436.50 Mn |
| Dec 31, 2025 | 436.50 Mn |